MARINA KAMYSHIN: Open Payments
NPI 1467601930 · THE WOODLANDS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 17 payments from 11 companies in 2025. Trend: 2023 $498 · 2024 $302 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $93 |
| PFIZER INC. | 2 | $58 |
| Seqirus USA Inc | 2 | $33 |
| Lilly USA, LLC | 1 | $24 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Dexcom, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $18 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
Products named: NURTEC ODT, Ozempic, Flucelvax, MOUNJARO, INSPIRE, Dexcom G6 Transmitter, Rybelsus, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
